Pharmaceutical Industry Information Portal

HomeNews

News

Moderna plans to expand its portfolio of global public health vaccines to 15 total programs

Moderna announces commitment to advance vaccines targeting 15 pathogens identified as biggest public health risk by WHO and CEPI into clinical studies by 2025 Moderna...

Lawmakers in the U.S. push for a permanent ban on illicit versions of fentanyl

A bipartisan trio of U.S. Congressmen on Monday unveiled new legislation that would permanently ban illicit versions of fentanyl, the powerful synthetic painkiller that...

Novartis and Voyager Therapeutics announce partnership to develop next-generation gene therapy for neurological diseases

Novartis today announced a license option agreement with Voyager Therapeutics, a gene therapy company focused on next-generation adeno-associated virus (AAV) technologies, for three capsids...

Moderna will establish mRNA vaccine manufacturing facility in Kenya

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that with the assistance of the U.S. Government, it has...

New DNA test for over 50 genetic diseases from Australia’s, Britain’s, and Israel’s team of scientists

A new DNA test, developed by researchers at the Garvan Institute of Medical Research in Sydney and collaborators from Australia, UK and Israel, has...

The importance of monitoring SARS-CoV-2 infection in wildlife

Food and Agriculture Organization (FAO), World Organisation for Animal Health (OIE) and World Health Organization (WHO) have made a joint statement on the prioritization...
spot_img

Expert Articles

spot_img